BRANFORD, Conn., April 08, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through ...

"We are very excited to share a comprehensive update across all of our development efforts and provide insights into our pipeline of new capabilities, that we believe, demonstrates that we have the ...

Proteus™ platform development including recent development data A long-term technology roadmap that addresses the path to billions of reads The path to coverage of all 20 amino acids A suite of ...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule ...

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the key ...

NEW YORK - Quantum-Si Incorporated (NASDAQ:QSI) announced significant progress on its Proteus protein analysis platform during its Investor & Analyst Day in New York City on Wednesday, according to a ...

The company expects adjusted operating expenses for 2025 to be $96 million or less and total cash use to be $103 million or less. Keyes noted, "this updated number of $103 million is inclusive of the ...